Zhejiang
300878.SZZhejiang Wecome Pharmaceutical Company Limited Price (300878.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
133,975,964
(7.469)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 135,059,810 | 153,276,986 | 207,742,355 | 282,091,952 | 406,528,838 | 577,652,191 | 641,800,892 | 622,766,990 | 632,953,240 | 531,291,689 | 519,621,071 |
| Net Income | 19,748,013 | 20,721,530 | 50,023,692 | 80,851,450 | 95,157,729 | 87,776,673 | 126,012,754 | 135,815,760 | 96,495,377 | 48,810,249 | -8,038,557 |
| FCF USD | 14,506,872 | 5,331,424 | -8,849,833 | 52,188,453 | -13,036,291 | -67,156,349 | -2,214,214 | -109,526,894 | -238,841,567 | -101,875,094 | -80,996,291 |
| OCF USD | 25,982,100 | 46,010,000 | 29,632,900 | 100,154,851 | 29,003,913 | 105,572,864 | 112,762,180 | 42,812,190 | -67,744,474 | 146,568,150 | 58,289,136 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 | 1.08 | 0.00 | 0.21 | 1.11 | -20.29 |
| D/E | 0.53 | 0.00 | 0.00 | 0.00 | 0.09 | 0.18 | 0.32 | 0.01 | 0.06 | 0.23 | 0.31 |
| CA/CL | 1.08 | 1.38 | 1.95 | 2.38 | 1.88 | 1.80 | 2.32 | 4.67 | 3.74 | 2.18 | 2.40 |
| TA/TL | 1.47 | 1.82 | 2.42 | 3.02 | 2.76 | 2.59 | 2.46 | 6.66 | 5.96 | 3.81 | 3.20 |
| Total Debt | 18,000,000 | 0 | 0 | 0 | 28,500,000 | 70,236,600 | 164,928,573 | 14,713,511 | 82,339,847 | 319,101,139 | 425,035,162 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 32.02% | 26.39% | 30.75% | 26.92% | 25.89% | 17.94% | 17.57% | 9.45% | 6.14% | 2.62% | -0.06% |
| ROE | 58.65% | 26.49% | 38.47% | 38.34% | 31.09% | 22.29% | 24.24% | 9.83% | 6.91% | 3.49% | -0.58% |
| ROA | 0.00% | 10.85% | 22.54% | 25.66% | 19.84% | 13.69% | 14.39% | 8.33% | 5.70% | 2.36% | -0.39% |
| NM % | 14.62% | 13.52% | 24.08% | 28.66% | 23.41% | 15.20% | 19.63% | 21.81% | 15.25% | 9.19% | -1.55% |
| FCF / R% | 0.00% | 3.48% | -4.26% | 18.50% | -3.21% | -11.63% | -0.35% | -17.59% | -37.73% | -19.17% | -15.59% |
| FCF / NI% | 100.86% | 28.40% | -17.69% | 64.55% | -13.70% | -76.51% | -1.76% | -80.71% | -247.38% | -225.79% | 1,007.60% |
| Operating Margin (OM) | 0.00 | 0.18 | 0.14 | 0.36 | 0.46 | 0.45 | 0.58 | 0.80 | 0.81 | 0.96 | 0.96 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.55 | 0.53 | 0.46 | 0.74 | 0.88 | 0.81 | 0.87 | 0.94 | 0.67 | 0.34 | -0.06 |
| SPS | 3.75 | 3.89 | 1.91 | 2.60 | 3.75 | 5.30 | 4.43 | 4.30 | 4.37 | 3.67 | 3.88 |
| OCPS | 0.72 | 1.17 | 0.27 | 0.92 | 0.27 | 0.97 | 0.78 | 0.30 | -0.47 | 1.01 | 0.44 |
| FCPS | 0.40 | 0.14 | -0.08 | 0.48 | -0.12 | -0.62 | -0.02 | -0.76 | -1.65 | -0.70 | -0.60 |
| BVPS | 0.95 | 1.99 | 1.20 | 1.94 | 2.82 | 3.61 | 3.59 | 9.56 | 9.73 | 9.75 | 10.50 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.55 | 0.53 | 0.46 | 0.74 | 0.88 | 0.81 | 0.87 | 0.94 | 0.67 | 0.34 | -0.06 |
| CAGR-SPS | 3.75 | 3.89 | 1.91 | 2.60 | 3.75 | 5.30 | 4.43 | 4.30 | 4.37 | 3.67 | 3.88 |
| CAGR-OCPS | 0.72 | 1.17 | 0.27 | 0.92 | 0.27 | 0.97 | 0.78 | 0.30 | -0.47 | 1.01 | 0.44 |
| CAGR-FCPS | 0.40 | 0.14 | -0.08 | 0.48 | -0.12 | -0.62 | -0.02 | -0.76 | -1.65 | -0.70 | -0.60 |
| CAGR-BVPS | 0.95 | 1.99 | 1.20 | 1.94 | 2.82 | 3.61 | 3.59 | 9.56 | 9.73 | 9.75 | 10.50 |